2 guaranteed-quality

Guaranteed Quality

Ingredients safety is our number one priority!

As part of our quality focus, we have developed and implemented a European Quality Management System in line with industry standards. Throughout the supply chain we are actively involved in supporting our suppliers and partners to comply with the current regulations for all the industries we are active in. Working within these guidelines enables us to not only meet but exceed the very highest quality standards for the distribution of our ingredients.

To secure our commitment to quality in our organisation, we have implemented several quality systems:

We also comply with sector specific industry demands like FairTrade, Roundtable on Sustainable Palm Oil (RSPO), Roundable on Responsible Soy (RTRS), SKAL Organic and Secure feed upon request.

Latest News

06 - 02 - 2020
Barentz international B.V. and Matco Foods Limited officially announce the start of a new Joint Venture in Pakistan, following agreement between both parties. The aim of the new activity is to better serve the rapidly growing Pakistani food processing market with a target group of 200 million citizens. Matco Foods has built up an extended network within the Pakistan local food industry Barentz International offers the broadest high-quality ingredients portfolio within the global life science markets Barentz Pakistan will primarily focus on the markets for Human Nutrition and Pharmaceutical products
26 - 11 - 2019
Barentz announces today that Cinven has agreed to invest in their company. Cinven is a leading international private equity firm focused on building world-class European and global companies. Barentz has a strong market position in a structurally growing market for life science ingredients The Cinven team knows the speciality ingredients distribution market well Cinven recognizes the opportunities for both organic and buy and build growth Financial terms of the transaction are not disclosed  
04 - 11 - 2019
Barentz, a leading distributor of ingredients in the life science markets, is pleased to announce it has acquired a majority shareholding in Czech Republic based IMCoPharma. Highlights: IMCoPharma is a leader in the pharmaceutical ingredients market in the CIS region and Ukraine Both Barentz and IMCoPharma are known for their deep technical knowledge and broad portfolio of pharmaceutical ingredients This strategic investment provides Barentz with the licensing capability to do business with all pharmaceutical companies in this attractive region IMCoPharma considers this acquisition as an opportunity for strengthening its position in this market and creating new opportunities